1887

Abstract

PCR-based detection of Mucorales species could improve diagnosis of suspected invasive fungal infection, leading to a better patient outcome. This study describes two independent probe-based real-time PCR tests for detection of clinically relevant Mucorales, targeting specific fragments of the 18S and the 28S rRNA genes. Both assays have a short turnaround time, allow fast, specific and very sensitive detection of clinically relevant Mucorales and have the potential to be used as quantitative tests. They were validated on various clinical samples (fresh and formalin-fixed paraffin-embedded specimens, mainly biopsies,  = 17). The assays should be used as add-on tools to complement standard techniques; a combined approach of both real-time PCR assays has 100 % sensitivity. Genus identification by subsequent sequencing is possible for amplicons of the 18S PCR assay. In conclusion, combination of the two independent Mucorales assays described in this study, 18S and 28S, detected all clinical samples associated with proven Mucorales infection ( = 10). Reliable and specific identification of Mucorales is a prerequisite for successful antifungal therapy as these fungi show intrinsic resistance to voriconazole and caspofungin.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000218
2016-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/3/227.html?itemId=/content/journal/jmm/10.1099/jmm.0.000218&mimeType=html&fmt=ahah

References

  1. Almyroudis N. G., Sutton D. A., Fothergill A. W., Rinaldi M. G., Kusne S. 2007; In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 51:2587–2590 [View Article][PubMed]
    [Google Scholar]
  2. Alvarez E., Sutton D. A., Cano J., Fothergill A. W., Stchigel A., Rinaldi M. G., Guarro J. 2009; Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol 47:1650–1656 [View Article][PubMed]
    [Google Scholar]
  3. Auberger J., Lass-Flörl C., Aigner M., Clausen J., Gastl G., Nachbaur D. 2012; Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother 67:2268–2273 [View Article][PubMed]
    [Google Scholar]
  4. Babouee B., Goldenberger D., Elzi L., Lardinois D., Sadowski-Cron C., Bubendorf L., Prince S. S., Battegay M., Frei R., Weisser M. 2013; Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease?. Clin Microbiol Infect 19:e354–e357 [View Article][PubMed]
    [Google Scholar]
  5. Babouee Flury B., Weisser M., Prince S. S., Bubendorf L., Battegay M., Frei R., Goldenberger D. 2014; Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?. BMC Infect Dis 14:692 [View Article][PubMed]
    [Google Scholar]
  6. Bernal-Martínez L., Buitrago M. J., Castelli M. V., Rodriguez-Tudela J. L., Cuenca-Estrella M. 2013; Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. Clin Microbiol Infect 19:E1–E7 [View Article][PubMed]
    [Google Scholar]
  7. Bialek R., Konrad F., Kern J., Aepinus C., Cecenas L., Gonzalez G. M., Just-Nübling G., Willinger B., Presterl E., other authors. 2005; PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 58:1180–1184 [View Article][PubMed]
    [Google Scholar]
  8. Bitar D., Van Cauteren D., Lanternier F., Dannaoui E., Che D., Dromer F., Desenclos J. C., Lortholary O. 2009; Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 15:1395–1401 [View Article][PubMed]
    [Google Scholar]
  9. Chamilos G., Lewis R. E., Kontoyiannis D. P. 2008; Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503–509 [View Article][PubMed]
    [Google Scholar]
  10. De Pauw B., Walsh T. J., Donnelly J. P., Stevens D. A., Edwards J. E., Calandra T., Pappas P. G., Maertens J., Lortholary O., other authors. 2008; Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821 [View Article][PubMed]
    [Google Scholar]
  11. Einsele H., Hebart H., Roller G., Löffler J., Rothenhofer I., Müller C. A., Bowden R. A., van Burik J., Engelhard D., other authors. 1997; Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 35:1353–1360[PubMed]
    [Google Scholar]
  12. Hata D. J., Buckwalter S. P., Pritt B. S., Roberts G. D., Wengenack N. L. 2008; Real-time PCR method for detection of zygomycetes. J Clin Microbiol 46:2353–2358 [View Article][PubMed]
    [Google Scholar]
  13. Hrncirova K., Lengerova M., Kocmanova I., Racil Z., Volfova P., Palousova D., Moulis M., Weinbergerova B., Winterova J., other authors. 2010; Rapid detection and identification of mucormycetes from culture and tissue samples by use of high-resolution melt analysis. J Clin Microbiol 48:3392–3394 [View Article][PubMed]
    [Google Scholar]
  14. Kang S. H., Kim H. S., Bae M. N., Kim J., Yoo J. Y., Lee K. Y., Lee D.-G., Kim H.-J. 2015; Fatal breakthrough mucormycosis in an acute myelogenous leukemia patient while on posaconazole prophylaxis. Infect Chemother 47:49–54 [View Article][PubMed]
    [Google Scholar]
  15. Kasai M., Harrington S. M., Francesconi A., Petraitis V., Petraitiene R., Beveridge M. G., Knudsen T., Milanovich J., Cotton M. P., other authors. 2008; Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol 46:3690–3702 [View Article][PubMed]
    [Google Scholar]
  16. Kontoyiannis D. P., Lionakis M. S., Lewis R. E., Chamilos G., Healy M., Perego C., Safdar A., Kantarjian H., Champlin R., other authors. 2005; Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191:1350–1360 [View Article][PubMed]
    [Google Scholar]
  17. Kwon-Chung K. J. 2012; Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis 54:(Suppl. 1)S8–S15 [View Article][PubMed]
    [Google Scholar]
  18. Lanternier F., Dannaoui E., Morizot G., Elie C., Garcia-Hermoso D., Huerre M., Bitar D., Dromer F., Lortholary O., French Mycosis Study Group. 2012; A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 54:(Suppl. 1)S35–S43 [View Article][PubMed]
    [Google Scholar]
  19. Lengerova M., Racil Z., Hrncirova K., Kocmanova I., Volfova P., Ricna D., Bejdak P., Moulis M., Pavlovsky Z., other authors. 2014; Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis. J Clin Microbiol 52:2824–2828 [View Article][PubMed]
    [Google Scholar]
  20. Meletiadis J., Roilides E. 2013; Rare invasive fungal infections: epidemiology, diagnosis and management. Curr Fungal Infect Rep 7:351–360 [View Article]
    [Google Scholar]
  21. Millon L., Larosa F., Lepiller Q., Legrand F., Rocchi S., Daguindau E., Scherer E., Bellanger A. P., Leroy J., Grenouillet F. 2013; Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis 56:e95–e101 [View Article][PubMed]
    [Google Scholar]
  22. Mousset S., Bug G., Heinz W. J., Tintelnot K., Rickerts V. 2010; Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transpl Infect Dis 12:261–264 [CrossRef]
    [Google Scholar]
  23. Perkhofer S., Lass-Flörl C., Hell M., Russ G., Krause R., Hönigl M., Geltner C., Auberger J., Gastl G., other authors. 2010; The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents 36:531–536 [View Article][PubMed]
    [Google Scholar]
  24. Petrikkos G., Skiada A., Lortholary O., Roilides E., Walsh T. J., Kontoyiannis D. P. 2012; Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:(Suppl. 1)S23–S34 [View Article][PubMed]
    [Google Scholar]
  25. Rickerts V., Just-Nübling G., Konrad F., Kern J., Lambrecht E., Böhme A., Jacobi V., Bialek R. 2006; Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 25:8–13 [View Article][PubMed]
    [Google Scholar]
  26. Roden M. M., Zaoutis T. E., Buchanan W. L., Knudsen T. A., Sarkisova T. A., Schaufele R. L., Sein M., Sein T., Chiou C. C., other authors. 2005; Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653 [View Article][PubMed]
    [Google Scholar]
  27. Rüping M. J., Heinz W. J., Kindo A. J., Rickerts V., Lass-Flörl C., Beisel C., Herbrecht R., Roth Y., Silling G., other authors. 2010; Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 65:296–302 [View Article][PubMed]
    [Google Scholar]
  28. Skiada A., Pagano L., Groll A., Zimmerli S., Dupont B., Lagrou K., Lass-Florl C., Bouza E., Klimko N., other authors. 2011; Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17:1859–1867 [View Article][PubMed]
    [Google Scholar]
  29. Skiada A., Lanternier F., Groll A. H., Pagano L., Zimmerli S., Herbrecht R., Lortholary O., Petrikkos G. L., European Conference on Infections in Leukemia. 2013; Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 98:492–504 [View Article][PubMed]
    [Google Scholar]
  30. Trifilio S., Singhal S., Williams S., Frankfurt O., Gordon L., Evens A., Winter J., Tallman M., Pi J., Mehta J. 2007; Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 40:451–456 [View Article][PubMed]
    [Google Scholar]
  31. Vitale R. G., de Hoog G. S., Schwarz P., Dannaoui E., Deng S., Machouart M., Voigt K., van de Sande W. W., Dolatabadi S., other authors. 2012; Antifungal susceptibility and phylogeny of opportunistic members of the order Mucorales. J Clin Microbiol 50:66–75 [View Article][PubMed]
    [Google Scholar]
  32. Voigt K., Cigelnik E., O'donnell K. 1999; Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal-DNA sequence data. J Clin Microbiol 37:3957–3964[PubMed]
    [Google Scholar]
  33. Walsh T. J., Anaissie E. J., Denning D. W., Herbrecht R., Kontoyiannis D. P., Marr K. A., Morrison V. A., Segal B. H., Steinbach W. J., other authors. 2008; Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360 [View Article][PubMed]
    [Google Scholar]
  34. White P. L., Wingard J. R., Bretagne S., Löffler J., Patterson T. F., Slavin M. A., Barnes R. A., Pappas P. G., Donnelly J. P. 2015; Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis 61:1293–1303 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000218
Loading
/content/journal/jmm/10.1099/jmm.0.000218
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error